Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Gelteq Limited (GELS)

NCM · Drug Manufacturers - Specialty & Generic

$0.59-0.07 (-11.21%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$6.3M
P/E (TTM)
EPS
$-0.44
Div Yield
52W Range
$0.39–$2.02
Beta

Company overview

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

Gelteq Limited has not issued a press release in this window.

SEC filings

All filings →

Gelteq Limited has not filed an SEC document in this window.

Gelteq Limited has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
51,361 sh● NEW
20,000 sh0.0%
13,953 sh-9.8%

People at Gelteq Limited

All people →

Quarterly financials

Full financials →
Revenue trend
06/25
NI
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.